ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
Daniel W. Lee(University of Virginia Cancer Center), Sattva S. Neelapu(The University of Texas MD Anderson Cancer Center), Frederick L. Locke(Moffitt Cancer Center), Marcela V. Maus(Center for Cancer Research), Lamis Eldjerou, Kevin J. Curran(Memorial Sloan Kettering Cancer Center), Jennifer N. Brudno(National Institutes of Health), Krishna V. Komanduri(University of Miami), John F. DiPersio(Washington University in St. Louis), Steven Z. Pavletic(National Institutes of Health), Stephan A. Grupp(Children's Hospital of Philadelphia), Rebecca Gardner(Seattle Children's Hospital), Armin Ghobadi(Washington University in St. Louis), Marcelo C. Pasquini(Cleveland Clinic), Noelle V. Frey(Hospital of the University of Pennsylvania), Cameron J. Turtle(The University of Sydney), Jae H. Park(Memorial Sloan Kettering Cancer Center), Elena Mead, William Y. Go(Amgen (United States)), Bianca Santomasso(Georgetown University), Karl S. Peggs(Royal London Hospital), Marcel R.M. van den Brink(City Of Hope National Medical Center)
Cited by 3,561
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2018|3.7k